Gilda Buccianti

  • Citations Per Year
Learn More
BACKGROUND Reducing the dietary glycaemic response has been proposed as a means of reducing the risk of diabetes. AIM To evaluate the effects of a new diabetes-specific formula (DSF) enriched with resistant starch type IV and fructose-free on postprandial glycaemia, insulinaemia and gastrointestinal hormones in healthy volunteers and in outpatient type 2(More)
BACKGROUND AND METHODS After the phase I-II clinical trials in 1986, several studies on the use of rHuEPO in the treatment of anemia of renal failure have been carried out and the drug has been introduced into clinical practice. In the present article we analyze the results of recombinant human erythropoietin (rh-EPO) therapy administered intravenously(More)
  • 1